The AHEPA University General Hospital, also known as AHEPA Hospital, is considered one of the biggest hospitals in Greece, based in Thessaloniki. Covers 680 beds and all the spectrum of medical and surgical specialities of medicine as well as the psychiatric sector.

There are 680 beds in AHEPA University Hospital.

During the past decade, AHEPA University Hospital conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 4 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 2 clinical trials were completed. i.e. 7.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AHEPA University Hospital" #1 sponsor was "Aristotle University Of Thessaloniki" with 19 trials, followed by "AHEPA University Hospital" with 16 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AHEPA University Hospital" #1 collaborator was "AHEPA University Hospital" with 5 trials as a collaborator, "LABNET IAE - Private Reference Diagnostic Laboratory" with 2 trials as a collaborator, "University Hospital of Crete" with 2 trials as a collaborator, "ANALYSIS MEDICAL SA" with 1 trials as a collaborator and "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "AHEPA University Hospital" are "Coronary Artery Disease" (7 trials), "Pulmonary Arterial Hypertension" (6 trials), "Goiter" (3 trials), "Hypertension" (3 trials) and "PAH" (3 trials). Many other conditions were trialed in "AHEPA University Hospital" in a lesser frequency.

Most popular intervention types in "AHEPA University Hospital" are "Drug" (31 trials), "Other" (8 trials), "Procedure" (8 trials), "Device" (5 trials) and "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ocrelizumab" (4 trials), "Antihistamine" (2 trials), "Carboplatin" (2 trials) and "Fenebrutinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "AHEPA University Hospital" are 65 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "AHEPA University Hospital". undefined are not yet recruiting, 16 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 37 completed trials in AHEPA University Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in AHEPA University Hospital, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 14 trials that are defined as “Not Applicable".